People news: Unigene Labs

Share this article:
Unigene Laboratories hired Alex Martin as VP, business development and head of commercial operations, a newly created position. He joins from Affectis Pharmaceuticals AG, where he most recently served as CEO. Prior to Affectis, Martin was COO, Intercept Pharmaceuticals; chief business officer and chief financial officer, BioXell; and held management positions of increasing responsibility at Novartis Pharma AG, Medscape and SmithKline Beecham.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions